University College Cork

Teagasc, the Agriculture and Food Development Authority

Agriculture and Food Development Authority (teagasc)

Teagasc Dairy Products Research Centre

Tate & Lyle Solutions USA LLC

Agriculture and Food Development Authority

Catherine Stanton

Paul Ross

Oskar Zelder

Fergus Shanahan

Colin Hill

John Francis Cryan

Bruno Kaesler

Noel Caplice

Gerald F Fitzgerald

Harriet Schellekens

Bernard Roy

Cristina Torres

Ted Dinan

R Paul Ross

Ger Fitzgerald

Tony Ryan

Ieva Laurie

Kavita Karnik

Kirstie Canene-Adams

Florence Herisson

Colin Department Of Microbiology Hill

Ger Department Of Microbiology Fitzgerald

A composition for use in a method of regulating or treating a metabolic disease or a symptom thereof, the composition comprising an isolated bacteria(DPC6108) deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 28 Nov. 2011 and accorded the accession number NCIMB 41903.

GABA-producing culturable bacteria and use for improving health

A strain ofAPC 1472 is described. The strain has weight lowering effects in-vivo, achieved through inducing satiety via decreased internalisation of the Ghrelin receptor, and therefore, decreased constitutive activity. Moreover, the strain also showed a trend towards decreased ghrelin receptor hypothalamic expression in HFD-fed mice when compared with vehicle control group. The strain also improves glucose tolerance and decreased insulin plasma levels in mice, indicating the strain in the prevention and/or treatment of Type II diabetes, especially in obese individuals.

for treating obesity and weight management

An isolated(DPC6426) strain deposited with the National Collection of Industrial and Marine Bacteria Limited (NCIMB) on 27 Jul. 2012 under NCIMB Deposit Accession No. 42015.

Exopolysaccharide-producing bacteria, and uses thereof for protecting heart health

The invention provides a probiotic composition to alleviateinfection in farm animals. The composition may comprise at least one ofsub-species, and. The composition maybe formulated as an animal feedstuff, or as a pharmaceutical composition.

Probiotic composition suitable for animals

The present invention relates to a process for the production of conjugated linoleic acid and a process for the production of triglycerides with an increased content of conjugated linoleic acid. Moreover, the invention relates to a nucleic acid sequence; a nucleic acid construct, a vector and transgenic organisms comprising at least one nucleic acid sequence or one nucleic acid construct which encodes a polypeptide with conjugated linoleic isomerase activity. Furthermore, the invention relates to the use of a microorganism of the genusas a probiotic.

Conjugated linoleic acid isomerase and a process for the production of conjugated linoleic acid

Growing community of inventors

Fermoy, Ireland

Catherine Stanton